About
Gi Innovation develops next-generation innovative drugs using proprietary high-throughput protein drug screening platforms, focusing on immune-oncology, allergy, metabolic diseases, and healthspan treatments with ongoing clinical trials including FDA fast-tracked immuno-oncology drug candidates.
Explore Gi Innovation's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.